Chinese Journal of Antituberculosis ›› 2023, Vol. 45 ›› Issue (5): 493-498.doi: 10.19982/j.issn.1000-6621.20220505
• Original Articles • Previous Articles Next Articles
Zhang Xin1, Liu Tao2, Shi Zhiguo2, Zhai Wenting2, Chen Bin2, Liu Wei2()
Received:
2022-12-23
Online:
2023-05-10
Published:
2023-04-25
Contact:
Liu Wei
E-mail:lw1200@sina.com
Supported by:
CLC Number:
Zhang Xin, Liu Tao, Shi Zhiguo, Zhai Wenting, Chen Bin, Liu Wei. Effect of sugammadex on plasma concentration of rocuronium and muscle relaxation recovery in elderly patients with pulmonary tuberculosis after lobectomy[J]. Chinese Journal of Antituberculosis, 2023, 45(5): 493-498. doi: 10.19982/j.issn.1000-6621.20220505
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20220505
临床特征 | 观察组(30例) | 对照组(31例) | 检验值 | P值 |
---|---|---|---|---|
年龄(岁, | 68.1±5.8 | 66.6±4.6 | t=1.121 | 0.267 |
性别[例,构成比(%)] | χ2=0.617 | 0.432 | ||
男性 | 11(36.7) | 14(45.2) | ||
女性 | 19(63.3) | 17(54.8) | ||
BMI( | 25.2±3.6 | 24.8±2.9 | t=0.479 | 0.634 |
ASA分级[例,构成比(%)] | χ2=0.300 | 0.584 | ||
Ⅱ | 21(70.0) | 20(64.5) | ||
Ⅲ | 9(30.0) | 11(35.5) | ||
术前PaO2(mmHg, | 88.6±14.9 | 89.8±19.3 | t=-0.271 | 0.787 |
术前PaCO2(mmHg, | 41.7±4.1 | 40.8±4.9 | t=0.777 | 0.440 |
FEV1(L, | 2.0±0.7 | 2.0±0.6 | t=0.001 | 0.999 |
FEV1/FVC(%, | 80.4±13.4 | 82.2±10.4 | t=-0.587 | 0.559 |
手术时间(min, | 153±71 | 151±45 | t=0.132 | 0.896 |
罗库溴铵用量(mg, | 88.6±30.5 | 91.7±21.7 | t=-0.459 | 0.648 |
组别 | 平均动脉压(mmHg,$\bar{x}$±s) | 心率(次/min) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
给药前 | 1min | 2min | 3min | 5min | 给药前 | 1min | 2min | 3min | 5min | |
观察组(30例) | 88.0± 14.2 | 89.9± 14.8 | 89.4± 14.4 | 88.0± 14.7 | 87.0± 16.0 | 59.0± 8.7 | 57.7± 8.9 | 57.5± 8.1 | 56.7± 9.4 | 57.8± 8.9 |
对照组(31例) | 91.9± 17.8 | 103.0± 18.1 | 102.4± 19.9 | 98.7± 19.5 | 95.9± 18.4 | 62.1± 10.2 | 71.9± 14.9 | 70.8± 14.2 | 66.5± 12.8 | 62.9± 10.1 |
t值 | -0.944 | -3.089 | -2.915 | -2.414 | -2.013 | -1.275 | -4.500 | -4.473 | -3.399 | -2.090 |
P值 | 0.349 | 0.003 | 0.005 | 0.019 | 0.049 | 0.207 | <0.001 | <0.001 | 0.001 | 0.041 |
[1] |
Cedborg AI, Sundman E, Bodén K, et al. Pharyngeal function and breathing pattern during partial neuromuscular block in the elderly: effects on airway protection. Anesthesiology, 2014, 120 (2): 312-325. doi:10.1097/ALN.0000000000000043.
doi: 10.1097/ALN.0000000000000043 pmid: 24162461 |
[2] |
Bartels K, Hunter J M. Neostigmine versus sugammadex: the tide may be turning, but we still need to navigate the winds. Br J Anaesth, 2020, 124 (5): 504-507. doi:10.1016/j.bja.2020.02.021.
doi: S0007-0912(20)30136-7 pmid: 32228868 |
[3] |
Moon TS, Reznik S, Pak T, et al. Sugammadex versus neostigmine for reversal of rocuronium-induced neuromuscular blockade: A randomized, double-blinded study of thoracic surgical patients evaluating hypoxic episodes in the early postoperative period. J Clin Anesth, 2020, 64: 109804. doi:10.1016/j.jclinane.2020.109804.
doi: 10.1016/j.jclinane.2020.109804 pmid: 32353805 |
[4] |
王斌, 周俊飞, 张欢. 年龄对持续输注罗库溴铵后肌松驰恢复的影响. 中华老年医学杂志, 2018, 37 (4): 441-444. doi:10.3760/cma.j.issn.0254-9026.2018.04.021.
doi: 10.3760/cma.j.issn.0254-9026.2018.04.021 |
[5] |
Adam JM, Bennett DJ, Bom A, et al. Cyclodextrin-derived host molecules as reversal agents for the neuromuscular blocker rocuronium bromide: synthesis and structure-activity relationships. J Med Chem, 2002, 45 (9): 1806-1816. doi:10.1021/jm011107f.
doi: 10.1021/jm011107f pmid: 11960492 |
[6] |
Brull SJ, Kopman AF. Current Status of Neuromuscular Reversal and Monitoring: Challenges and Opportunities. Anesthesiology, 2017, 126 (1): 173-190. doi:10.1097/ALN.0000000000001409.
doi: 10.1097/ALN.0000000000001409 pmid: 27820709 |
[7] |
Honing G, Martini CH, Bom A, et al. Safety of sugammadex for reversal of neuromuscular block. Expert Opin Drug Saf, 2019, 18 (10): 883-891. doi:10.1080/14740338.2019.1649393.
doi: 10.1080/14740338.2019.1649393 pmid: 31359807 |
[8] |
Dewan RK, Pezzella AT. Surgical aspects of pulmonary tuberculosis: an update. Asian Cardiovasc Thorac Ann, 2016, 24(8):835-846. doi:10.1177/0218492316661958.
doi: 10.1177/0218492316661958 URL |
[9] |
蒋钰辉, 申磊, 戴希勇. 单向式肺叶切除术在复杂肺结核手术中应用的回顾性队列研究. 中国胸心血管外科临床杂志, 2022, 29(12):1607-1611. doi:10.7507/1007-4848.202012082.
doi: 10.7507/1007-4848.202012082 |
[10] |
Sparr HJ, Vermeyen KM, Beaufort AM, et al. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics. Anesthesiology, 2007, 106 (5): 935-943. doi:10.1097/01.anes.0000265152.78943.74.
doi: 10.1097/01.anes.0000265152.78943.74 pmid: 17457124 |
[11] |
Gijsenbergh F, Ramael S, Houwing N, et al. First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide. Anesthesiology, 2005, 103 (4): 695-703. doi:10.1097/00000542-200510000-00007.
doi: 10.1097/00000542-200510000-00007 pmid: 16192761 |
[12] |
Carron M, Bertoncello F, Ieppariello G. Profile of sugammadex for reversal of neuromuscular blockade in the elderly: current perspectives. Clin Interv Aging, 2018, 13: 13-24. doi:10.2147/CIA.S134108.
doi: 10.2147/CIA.S134108 pmid: 29317806 |
[13] |
Lee LA, Athanassoglou V, Pandit JJ. Neuromuscular blockade in the elderly patient. J Pain Res, 2016, 9: 437-444. doi:10.2147/JPR.S85183.
doi: 10.2147/JPR.S85183 pmid: 27382330 |
[14] |
Carron M, Zarantonello F, Tellaroli P, et al. Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials. J Clin Anesth, 2016, 35: 1-12. doi:10.1016/j.jclinane.2016.06.018.
doi: S0952-8180(16)30293-8 pmid: 27871504 |
[15] |
王娟, 周玲, 黄河. 舒更葡糖钠对房颤患者非心脏手术围拔管期血流动力学和相关并发症的影响. 南京医科大学学报(自然科学版), 2021, 41 (10): 1521-1523, 1532. doi:10.7655/NYDXBNS20211018.
doi: 10.7655/NYDXBNS20211018 |
[16] |
Li L, Jiang Y, Zhang W. Sugammadex for Fast-Track Surgery in Children Undergoing Cardiac Surgery: A Randomized Controlled Study. J Cardiothorac Vasc Anesth, 2020, 35 (5): 1388-1392. doi:10.1053/j.jvca.2020.08.069.
doi: 10.1053/j.jvca.2020.08.069 URL |
[17] |
Won YJ, Lim BG, Lee DK, et al. Sugammadex for reversal of rocuronium-induced neuromuscular blockade in pediatric patients: A systematic review and meta-analysis. Medicine (Baltimore), 2016, 95 (34): e4678. doi:10.1097/MD.0000000000004678.
doi: 10.1097/MD.0000000000004678 URL |
[18] |
Abad-Gurumeta A, Ripollés-Melchor J, Casans-Francés R, et al. A systematic review of sugammadex vs neostigmine for reversal of neuromuscular blockade. Anaesthesia, 2015, 70 (12): 1441-1452. doi:10.1111/anae.13277.
doi: 10.1111/anae.13277 pmid: 26558858 |
[19] |
Wang JF, Zhao ZZ, Jiang ZY, et al. Influence of sugammadex versus neostigmine for neuromuscular block reversal on the incidence of postoperative pulmonary complications: a meta-analysis of randomized controlled trials. Perioper Med (Lond), 2021, 10 (1): 32. doi:10.1186/s13741-021-00203-6.
doi: 10.1186/s13741-021-00203-6 |
[20] |
中华医学会麻醉学分会.肌肉松弛药合理应用的专家共识(2013). 临床麻醉学杂志, 2013, 29 (7): 712-715. doi:10.3760/cma.j.issn.1673-4378.2013.07.001.
doi: 10.3760/cma.j.issn.1673-4378.2013.07.001 |
[1] | Zhu Jiankun, Meng Qian, Kong Kangbao, Jin Feng. The value of pneumonectomy in the treatment of pulmonary mucormycosis [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 274-281. |
[2] | Gong Sheng, Wang Ning, Li Dan, Li Gang, Liu Yu, Jiang Liangshuang, Yao Xiaojun. Comparative study of fluorescence staining method and inflation-deflation method for thoracoscopic pulmonary tuberculosis segmentectomy [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 292-297. |
[3] | Zhang Mengdi, Wang Qiqi, Wang Xin, Zheng Wenjing, Sun Wenshan, Xiao Yiran, Guo Xiaomin, Liu Jianjun, Huang Fei, Yao Hongyan. Study on pulmonary tuberculosis disease burden in the elderly aged 60 and above in China, 2005—2020 [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 338-347. |
[4] | Qin Xueling, Chen Li, Sun Xiaoying, Hu Shanpeng, Lu Zhen, He Nailing, Zhang Jifen. Active screening and influencing factor analysis of pulmonary tuberculosis among elderly people [J]. Chinese Journal of Antituberculosis, 2025, 47(3): 355-361. |
[5] | Pan Meimin, Li Wenjuan, Zhang Xuehong, Yang Lihui, He Juan, Tan Yongwei. Study on serum TNFSF14 and sIL-2R levels in elderly patients with pulmonary tuberculosis and their correlation with short-term prognosis [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 66-71. |
[6] | Sun Danyuchen, Liu Yuhong. Research progress on active case finding of tuberculosis in the elderly population: a literature review [J]. Chinese Journal of Antituberculosis, 2025, 47(1): 96-101. |
[7] | Ye Zhiteng, Ren Fei, Wang Hua, Yang Ming, Chen Yu, Chen Xiaohong, Wang Yun, Fan Lin. Treatment outcomes and influencing factors in elderly patients with multidrug/rifampicin-resistant pulmonary tuberculosis: a national multicenter, retrospective cohort study [J]. Chinese Journal of Antituberculosis, 2024, 46(9): 1023-1029. |
[8] | Zhou Xue, He Fang, Di Yicheng, Zhang Zheng, Liu Ju. Analysis of risk factors of respiratory failure in elderly patients with pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(3): 357-361. |
[9] | Zheng Guangmin, Wang Ting, Zhang Danni, Lei Yu, Yang Jieying, Wu Guifeng, Du Yuhua, Xiao Xincai. Evaluation on the implementation effect of different tuberculosis prevention and control management models during the 13th Five-Year Plan period in Guangzhou [J]. Chinese Journal of Antituberculosis, 2024, 46(2): 199-205. |
[10] | Guo Jing, Liu Zhongda, Zhang Zunjing, Luo Shuirong. Progress in Traditional Chinese Medicine diagnosis and treatment of elderly pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(11): 1406-1409. |
[11] | Zhang Mengdi, Wang Xin, Zheng Wenjing, Wang Qiqi, Li Tao, Wang Ni, Liu Jianjun, Huang Fei, Yao Hongyan. Research progresses of risk factors for tuberculosis in the elderly [J]. Chinese Journal of Antituberculosis, 2024, 46(10): 1266-1272. |
[12] | Tian Xiaomei, Sha Xiaolan, Liu Ye, Liu Guangtian, Lei Juan. An analysis of the epidemic characteristics and treatment outcomes of tuberculosis patients aged ≥65 years old in Ningxia Hui Autonomous Region from 2019 to 2022 [J]. Chinese Journal of Antituberculosis, 2023, 45(9): 857-863. |
[13] | Wu Tana, Li Yuhong, Liu Xiaoqiu. Study on the feasibility of active tuberculosis screening strategy for the elderly based on public health service [J]. Chinese Journal of Antituberculosis, 2023, 45(4): 372-376. |
[14] | Dai Zhenwei, Zhang Haoran, Jing Shu, Xiao Weijun, Wang Hao, Huang Yiman, Chen Xu, Fu Jiaqi, Wu Yijin, Gao Lei, Su Xiaoyou. Effect of mindfulness level on mental health of middle-aged and elderly people with type 2 diabetes mellitus comorbidity latent tuberculosis infection in rural areas [J]. Chinese Journal of Antituberculosis, 2023, 45(2): 188-194. |
[15] | Wang Bo, He Aiwei, Yang Shumin, Zhao Jianxi, Bai Yu’e, Guo Qiang, Ma Yubao, Liu Fang. Analysis of spatial-temporal feature of notified pulmonary tuberculosis cases aged 60 years and above in Gansu Province from 2018 to 2022 [J]. Chinese Journal of Antituberculosis, 2023, 45(12): 1164-1169. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||